1180500

AxoGen Corporation — FEI 3012085771

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 22, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Dayton, OH (United States)